Dr. Michael Milosevic is a radiation oncologist and one of the three directors of the STTARR Innovation Centre which is focused on radiation therapy research. He specializes in the treatment of gynecological and prostate cancers, and is currently leading several patient studies focused on understanding how abnormal tumour blood flow and metabolism influence the response to treatments like radiation therapy. One study, for example, is combining the use of a drug that blocks the formation of new blood vessels with radiation treatment.
Link to this comment:
All Comments (0)